Vous avez cherché: smallpox (Anglais - Maltais)

smallpox
gidri r-rih

"smallpox
"il-Ġidri

licensed smallpox vaccine
tilqima liċenzjata kontra l-ġidri

imvanex® suspension for injection smallpox vaccine
imvanex® suspensjoni għall-injezzjoni tilqima kontra l-ġidri

if you have never been vaccinated against smallpox:
jekk qatt ma tlaqqamt kontra l-ġidri:

smallpox vaccine (live modified vaccinia virus ankara)
tilqima kontra l-ġidri (vaccinia virus ankara Ħaj modifikat)

booster vaccination (individuals previously vaccinated against smallpox):
tilqima booster (individwi li fil-passat tlaqqmu kontra l-ġidri):

imvanex is a vaccine used to prevent smallpox infection in adults.
imvanex hu tilqima li tintuża għall-prevenzjoni ta’ infezzjoni tal-ġidri fl-adulti.

isolation of smallpox (variola) virus from a clinical specimen.
l-iżolazzjoni tal-virus tal-ġidri (variola) minn kampjun klinikali.

most member states have existing or are acquiring stockpiles of smallpox vaccines.
il-biċċa l-kbira ta’ l-istati membri għandhom jew qed jiksbu ħażniet ta’ tilqim kontra l-ġidri.

there are no authorised vaccines in the eu against pathogens such as smallpox or plague.
m’hemm l-ebda tilqim awtorizzat fl-ue kontra l-patoġeni bħall-ġidri jew il-pesta.

you can be given this vaccine whether or not you have received smallpox vaccination in the past.
tista’ tingħata din it-tilqima sew jekk fl-passat kont irċevejt tilqima kontra l-ġidri u sew jekk le.

smallpox was officially declared eradicated in 1980 with the last known case of the disease occurring in 1977.
il-ġidri ġiet uffiċjalment eradikata fl-1980 bl-aħħar każ magħruf tal-marda jseħħ fl-1977.

active immunisation against smallpox in adults (see sections 4.4 and 5.1).
tilqima attiva kontra l-ġidri fl-adulti (ara sezzjonijiet 4.4 u 5.1).

the global eradication of smallpox and the elimination of poliomyelitis from most countries were cited as examples of successful vaccination programmes.
l-eradikazzjoni globali tal-ġidri u l-eliminazzjoni tal-poljomelite mill-biċċa l-kbira tal-pajjiżi issemmew bħala eżempji ta' programmi ta' tilqim b'suċċess.

a study by the commission on the dilution of existing smallpox vaccines showed that it would be problematic under emergency conditions.
studju mill-kummissjoni dwar id-dilwizzjoni tat-tilqim eżistenti kontra l-ġidri wera li din tista’ taqla’ problema f’kundizzjonijiet ta’ emerġenza.

because of its similarities to the smallpox virus, the antibodies produced against this virus are also expected to protect against smallpox.
minħabba s-similaritajiet tiegħu għall-virus tal-ġidri, l-antikorpi prodotti kontra dan il-virus huma mistennija wkoll jipproteġu kontra l- ġidri.

eu- wide evaluation exercises on smallpox and pandemic influenza will be carried out in 2005 to evaluate communications and compatibility of national plans.
fl-2005, se jitwettqu eżerċizzji madwar l-ue ta’ valutazzjoni dwar il-ġidri u l-influwenza pandemika sabiex jiġu vvalutati l-komunikazzjonijiet u l-kompatibbiltà tal-pjanijiet nazzjonali.

as a precautionary measure the use of imvanex should be avoided during pregnancy unless it is considered that the possible benefit in terms of preventing smallpox would outweigh the potential risk.
bħala miżura ta’ prekawzjoni, l-użu ta’ imvanex għandu jiġi evitat matul it-tqala ħlief jekk jiġi kkunsidrat li l-benefiċċju possibbli f’termini ta’ prevenzjoni tal-ġidri jkun jegħleb ir-riskju potenzjali.

although the studies showed that imvanex is expected to protect against smallpox, it is not possible to determine from study results the exact level of protection or how long the protection would last.
għalkemm l-istudji wrew li imvanex huwa mistenni jipproteġi kontra ġidri, mhuwiex possibbli li mir-riżultati tal-istudju jiġi determinat il-livell eżatt ta’ protezzjoni jew it-tul ta’ żmien li l-protezzjoni ddum.